Dynavax Technologies Corporation (DVAX)
Company Info
US2681582019
268158201
Feb 19, 2004
Highlights
$1.44B
$0.20
58.75
$226.46M
$187.98M
$40.07M
$9.74 - $14.63
$24.25
21.52%
6.98
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Dynavax Technologies Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Dynavax Technologies Corporation (DVAX) returned -14.49% year-to-date (YTD) and -6.19% over the past 12 months. Over the past 10 years, DVAX returned -5.87% annually, underperforming the S&P 500 benchmark at 10.26%.
DVAX
-14.49%
-13.68%
-9.08%
-6.19%
19.27%
-5.87%
^GSPC (Benchmark)
-4.67%
10.50%
-3.04%
8.23%
14.30%
10.26%
Monthly Returns
The table below presents the monthly returns of DVAX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.19% | 5.67% | -5.95% | -9.41% | -7.06% | -14.49% | |||||||
| 2024 | -7.58% | -1.93% | -2.05% | -8.38% | 5.45% | -6.34% | -0.36% | 0.27% | -0.71% | 6.37% | 8.52% | -0.70% | -8.66% |
| 2023 | 6.95% | -9.49% | -4.76% | 6.12% | 9.80% | 13.04% | 8.28% | 2.64% | 2.86% | -3.79% | -3.59% | 2.04% | 31.39% |
| 2022 | -7.82% | -5.47% | -11.58% | -18.54% | 34.31% | 6.16% | 14.22% | -20.24% | -8.98% | 9.67% | 8.38% | -14.26% | -24.38% |
| 2021 | 41.80% | 38.67% | 12.34% | 1.53% | -17.84% | 20.12% | -5.18% | 108.35% | -1.28% | 3.96% | -19.13% | -12.88% | 216.18% |
| 2020 | -11.71% | -21.88% | -10.52% | 20.40% | 44.00% | 44.93% | -8.57% | -26.26% | -27.76% | -13.66% | 36.19% | -12.40% | -22.20% |
| 2019 | 20.44% | -16.52% | -20.54% | -9.03% | -27.52% | -17.22% | -30.83% | 50.00% | -13.65% | 42.38% | 11.00% | 1.24% | -37.49% |
| 2018 | -13.90% | 0.31% | 22.91% | -14.61% | -6.78% | -3.48% | -11.48% | 2.59% | -10.47% | -20.24% | 14.26% | -19.03% | -51.07% |
| 2017 | 3.80% | 9.76% | 32.22% | -6.72% | -0.90% | 75.45% | 64.25% | 13.25% | 19.78% | 2.33% | -9.09% | -6.50% | 373.42% |
| 2016 | -0.29% | -33.08% | 19.35% | -14.71% | 1.10% | -12.12% | 5.83% | 1.49% | -33.01% | -11.82% | -53.51% | -8.14% | -83.65% |
| 2015 | 1.42% | 2.92% | 27.44% | -10.32% | 13.20% | 2.88% | 25.55% | -3.57% | -13.47% | -7.46% | 22.81% | -13.37% | 43.30% |
| 2014 | -11.22% | 6.90% | -2.82% | -9.82% | -11.66% | 11.11% | -7.50% | -4.05% | 0.70% | 14.69% | -9.39% | 13.46% | -13.98% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of DVAX is 39, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Dynavax Technologies Corporation (DVAX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Dynavax Technologies Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Dynavax Technologies Corporation was 98.47%, occurring on Nov 20, 2008. The portfolio has not yet recovered.
The current Dynavax Technologies Corporation drawdown is 88.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.47% | Dec 12, 2006 | 490 | Nov 20, 2008 | — | — | — |
| -61.81% | Feb 20, 2004 | 291 | Apr 15, 2005 | 410 | Nov 29, 2006 | 701 |
| -7.25% | Nov 30, 2006 | 2 | Dec 1, 2006 | 6 | Dec 11, 2006 | 8 |
Volatility
Volatility Chart
The current Dynavax Technologies Corporation volatility is 15.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Dynavax Technologies Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Dynavax Technologies Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 25.0% positive surprise.
Valuation
The Valuation section provides an overview of how Dynavax Technologies Corporation is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DVAX, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, DVAX has a P/E ratio of 58.8. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for DVAX compared to other companies in the Drug Manufacturers - Specialty & Generic industry. DVAX currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DVAX relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, DVAX has a P/S ratio of 5.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DVAX in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, DVAX has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |